🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Reliability of AAR as an Independent Tool for Surgical Indication in Nasal Obstruction

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier Intercommunal de Toulon La Sey…
NCT07379775 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Nasal obstruction (NO) affects \~30% of the population and is a very common reason for consultation in otorhinolaryngology (ORL). In the majority of cases, the origin is inflammatory (allergic rhinitis and chronic rhinosinusitis) while in a minority of cases, the origin is structural, including septal deviation and inferior turbinate hypertrophy. NO significantly impairs patients' quality of life (QoL) and olfactory performance and also represents a contributing factor and comorbidity in asthma and obstructive sleep apnea syndrome. Several questionnaires for assessing QoL are available and routinely used to evaluate the impact of NO on patients : VAS, NOSE score, SNOT-22, and RhinoQOL score. Several objective functional methods for assessing NO have been described : acoustic rhinometry, nasal peak inspiratory flow, and active rhinomanometry. Rhinomanometry is a simple, non-invasive fun

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients aged 18 years or older with nasal obstruction (NO). 2. Patients scheduled for surgery: septoplasty ± turbinoplasty ± rhinoplasty for nasal obstruction. 3. Patients who have undergone a preoperative rhinomanometry assessment. 4. Patients consented to participation Exclusion Criteria: 1. Nasal polyps. 2. Chronic edematous-purulent rhinosinusitis (e.g., cystic fibrosis). 3. Crusting rhinosinusitis (e.g., sarcoidosis, granulomatosis with polyangiitis \[Wegener's\]). 4. Current or previously treated nasal or sinus tumors, or patients undergoing tumor work-up
💊

What it tests

  • preoperative rhinomanometry
📍

Where

1 site
Centre Hospitalier de la Dracénie
Draguignan, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy